Altered Monocyte and Langerhans Cell Innate Immunity in Patients With Recurrent Respiratory Papillomatosis (RRP)

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2020 Mar 27

PMID 32210959

Citations 16

Authors

Mohd Israr

James A DeVoti

Fung Lam

Allan L Abramson

Bettie M Steinberg

Vincent R Bonagura

Affiliations

Soon will be listed here.

Abstract

The micromilieu within respiratory papillomas supports persistent human papillomavirus (HPV) infection and disease recurrence in patients with recurrent respiratory papillomatosis (RRP). These patients show polarized (T2-/Treg) adaptive immunity in papillomas and blood, enriched immature Langerhans cell (iLC) numbers, and overexpression of cyclooxygenase-2/prostaglandin E (PGE) in the upper airway. Blood monocyte-derived, and tissue-derived iLCs from RRP patients and controls were now studied to more fully understand innate immune dysregulation in RRP. Patients' monocytes generated fewer iLCs than controls, due to a reduced fraction of classical monocytes that generated most but not all the iLCs. Prostaglandin E, which was elevated in RRP plasma, reduced monocyte-iLC differentiation from controls to the levels of RRP patients, but had no effect on subsequent iLC maturation. Cytokine/chemokine responses by iLCs from papillomas, foreskin, and abdominal skin differed significantly. Freshly derived tissue iLCs expressed low and high mRNAs and were unresponsive to IL-36γ stimulation. Papilloma iLCs uniquely expressed IL-36γ at baseline and expressed when cultured overnight outside their immunosuppressive microenvironment without additional stimulation. We conclude that monocyte/iLC innate immunity is impaired in RRP, in part due to increased PGE exposure . The immunosuppressive papilloma microenvironment likely alters iLC responses, and vice versa, supporting T2-like/Treg HPV-specific adaptive immunity in RRP.

Citing Articles

DNA immunotherapy for recurrent respiratory papillomatosis (RRP): phase 1/2 study assessing efficacy, safety, and immunogenicity of INO-3107.

Morrow M, Gillespie E, Sylvester A, Amin M, Belafsky P, Best S Nat Commun. 2025; 16(1):1518.

PMID: 39939590 PMC: 11821913. DOI: 10.1038/s41467-025-56729-6.

Characterization of HPV6/11-reactive T-cell subsets in papillomas of patients with juvenile-onset recurrent respiratory papillomatosis and identification of HPV11 E7-specific candidate TCR clonotypes.

Peng Y, Wang W, Liu X, Li S, Zhang J, Ni X J Virol. 2024; 98(10):e0067724.

PMID: 39258910 PMC: 11495051. DOI: 10.1128/jvi.00677-24.

The role of HPV11 E7 in modulating STING-dependent interferon β response in recurrent respiratory papillomatosis.

Chen L, Hu H, Pan Y, Lu Y, Zhao M, Zhao Y J Virol. 2024; 98(5):e0192523.

PMID: 38624230 PMC: 11092327. DOI: 10.1128/jvi.01925-23.

Profiling of VEGF Receptors and Immune Checkpoints in Recurrent Respiratory Papillomatosis.

Lam B, Miller J, Kung Y, Wu T, Hung C, Roden R Laryngoscope. 2024; 134(6):2819-2825.

PMID: 38193541 PMC: 11078620. DOI: 10.1002/lary.31253.

Involvement of TLR9 in priming the immune response in oral papillomatosis induced by low-risk HPV.

Andrei E, Munteanu M, Busuioc C, Pisoschi C, Mateescu G, Dracea S Rom J Morphol Embryol. 2023; 64(2):181-188.

PMID: 37518875 PMC: 10520400. DOI: 10.47162/RJME.64.2.08.

References

Durham B, Roos-Weil D, Baillou C, Cohen-Aubart F, Yoshimi A, Miyara M . Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells. Blood. 2017; 130(2):176-180. PMC: 5510787. DOI: 10.1182/blood-2016-12-757377. View

Breyer R, Bagdassarian C, Myers S, Breyer M . Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol. 2001; 41:661-90. DOI: 10.1146/annurev.pharmtox.41.1.661. View

Sere K, Baek J, Ober-Blobaum J, Muller-Newen G, Tacke F, Yokota Y . Two distinct types of Langerhans cells populate the skin during steady state and inflammation. Immunity. 2012; 37(5):905-16. DOI: 10.1016/j.immuni.2012.07.019. View

Wu R, Abramson A, Shikowitz M, Dannenberg A, Steinberg B . Epidermal growth factor-induced cyclooxygenase-2 expression is mediated through phosphatidylinositol-3 kinase, not mitogen-activated protein/extracellular signal-regulated kinase kinase, in recurrent respiratory papillomas. Clin Cancer Res. 2005; 11(17):6155-61. DOI: 10.1158/1078-0432.CCR-04-2664. View

Ginhoux F, Jung S . Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat Rev Immunol. 2014; 14(6):392-404. DOI: 10.1038/nri3671. View

Peiser M, Wanner R, Kolde G . Human epidermal Langerhans cells differ from monocyte-derived Langerhans cells in CD80 expression and in secretion of IL-12 after CD40 cross-linking. J Leukoc Biol. 2004; 76(3):616-22. DOI: 10.1189/jlb.0703327. View

Hatam L, DeVoti J, Rosenthal D, Lam F, Abramson A, Steinberg B . Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression. Clin Cancer Res. 2012; 18(7):1925-35. PMC: 3319851. DOI: 10.1158/1078-0432.CCR-11-2941. View

Clancy D, Sullivan G, Moran H, Henry C, Reeves E, McElvaney N . Extracellular Neutrophil Proteases Are Efficient Regulators of IL-1, IL-33, and IL-36 Cytokine Activity but Poor Effectors of Microbial Killing. Cell Rep. 2018; 22(11):2937-2950. DOI: 10.1016/j.celrep.2018.02.062. View

Bonagura V, Hatam L, DeVoti J, Zeng F, Steinberg B . Recurrent respiratory papillomatosis: altered CD8(+) T-cell subsets and T(H)1/T(H)2 cytokine imbalance. Clin Immunol. 1999; 93(3):302-11. DOI: 10.1006/clim.1999.4784. View

10.

Merad M, Manz M . Dendritic cell homeostasis. Blood. 2009; 113(15):3418-27. PMC: 2668851. DOI: 10.1182/blood-2008-12-180646. View

11.

Igyarto B, Kaplan D . Antigen presentation by Langerhans cells. Curr Opin Immunol. 2012; 25(1):115-9. PMC: 3593958. DOI: 10.1016/j.coi.2012.11.007. View

12.

Bennett C, Fallah-Arani F, Conlan T, Trouillet C, Goold H, Chorro L . Langerhans cells regulate cutaneous injury by licensing CD8 effector cells recruited to the skin. Blood. 2011; 117(26):7063-9. PMC: 3336775. DOI: 10.1182/blood-2011-01-329185. View

13.

Riedl E, Stockl J, Majdic O, Scheinecker C, Knapp W, Strobl H . Ligation of E-cadherin on in vitro-generated immature Langerhans-type dendritic cells inhibits their maturation. Blood. 2000; 96(13):4276-84. View

14.

Zhang C, Qi Y, Li X, Yang Y, Liu D, Zhao J . The role of CCL20/CCR6 axis in recruiting Treg cells to tumor sites of NSCLC patients. Biomed Pharmacother. 2015; 69:242-8. DOI: 10.1016/j.biopha.2014.12.008. View

15.

Karatayli-Ozgursoy S, Bishop J, Hillel A, Akst L, Best S . Risk Factors for Dysplasia in Recurrent Respiratory Papillomatosis in an Adult and Pediatric Population. Ann Otol Rhinol Laryngol. 2015; 125(3):235-41. DOI: 10.1177/0003489415608196. View

16.

Tavian M, Peault B . Embryonic development of the human hematopoietic system. Int J Dev Biol. 2005; 49(2-3):243-50. DOI: 10.1387/ijdb.041957mt. View

17.

Israr M, Rosenthal D, Frejo-Navarro L, DeVoti J, Meyers C, Bonagura V . Microarray analysis of human keratinocytes from different anatomic sites reveals site-specific immune signaling and responses to human papillomavirus type 16 transfection. Mol Med. 2018; 24(1):23. PMC: 6016891. DOI: 10.1186/s10020-018-0022-9. View

18.

Di Gennaro P, Romoli M, Gerlini G, DAmico M, Brandani P, Pimpinelli N . IDO and CD83 expression in human epidermal Langerhans cells. J Dermatol Sci. 2013; 73(2):172-4. DOI: 10.1016/j.jdermsci.2013.10.005. View

19.

Seneschal J, Clark R, Gehad A, Baecher-Allan C, Kupper T . Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells. Immunity. 2012; 36(5):873-84. PMC: 3716276. DOI: 10.1016/j.immuni.2012.03.018. View

20.

Steinberg B, Abramson A, Meade R . Culture of human laryngeal papilloma cells in vitro. Otolaryngol Head Neck Surg. 1982; 90(6):728-35. DOI: 10.1177/019459988209000610. View